I still remember the 29 tiny black coffins - each with a white cross - laid out in front of the General Medical Council. That was 1998 and the start of the disciplinary hearing into failures of two surgeons at Bristol Royal Infirmary.
The Bristol heart scandal led to a wide-ranging inquiry which concluded in 2001 that dozens of babies had died needlessly. It recommended that children's heart surgery should be carried out in fewer specialist centres.
The emergence of the novel coronavirus is a reminder of the potential threat we face from emerging diseases. A decade ago hundreds of people were killed by severe acute respiratory syndrome (SARS).
Although the novel coronavirus is from the same large family of pathogens as SARS, it is very different. And although media reports usually mentions the new virus and SARS in the same breath it is worth pointing out that coronaviruses also produce infections like the common cold.
There is a new disease in town - at least there is if you live in eastern China. Long after most people had lost interest in - and the media had stopped writing about - H5N1 bird flu, we now have to get used to another assortment of letters and numbers. So should we all worry about H7N9?
"Yes and no" seems to sum up the view of experts. Yes, because of the potential of flu viruses to cause global disease outbreaks - pandemics. No, because the virus is still confined to China and has no ability at present to transmit between humans.
What is it about the Italians? They smoke more than us, they earn less, their economy is in even worse shape than ours, they spend less on healthcare, and yet - they live longer. Not just a bit, but a whopping 18 months more on average.
They also have more years of good health before disease and disability set in.
If you signed up to a medical trial you might assume that the results of the research would eventually be published. But that is far from certain. Pharmaceutical companies are under no legal obligation to publish all the available data about drugs.
A group of 53 clinical trial participants has written an open letter to the European Medicines Agency - the body which licenses drugs. Some of the individuals are healthy volunteers and other have conditions like cancer.
Urgent appeals for blood donors seem to be a regular event - certainly at this time of year. So what triggers an appeal and is it feasible that we could ever run out of blood?
NHS Blood and Transplant (NHSBT), which runs the service in England and north Wales, put out an urgent appeal for O negative donors last week. It currently has just 3.2 days of O neg blood, while the Welsh Blood Service has four days and the Scottish Blood Transfusion Service has 6.1 days.
This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.